Dr. Don Chamil Codipilly, MD

Dr. Codipilly practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Codipilly's NPI, 1861870289, was assigned on May 18, 2015. Dr. Codipilly graduated from Renaissance School of Medicine at Stony Brook University in 2015. Dr. Codipilly holds Minnesota license 61020.

Dr. Codipilly's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Codipilly's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Codipilly to 2 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Codipilly practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Codipilly's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Codipilly is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Codipilly's licenses on file in 2 states: Minnesota and Wisconsin.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding and upper GI endoscopy among the conditions Dr. Codipilly treats.

CMS data shows 409 Medicare services from Dr. Codipilly across 15 procedure codes in 2024, for 348 Medicare patients. Medicare paid $40,079 for them.

CMS counts 348 Medicare patients who saw Dr. Codipilly in 2024. The largest group is 65 to 74, with 183 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Codipilly's median patient age at 69, with 41% women.

In 2024, Dr. Codipilly wrote 266 Medicare Part D claims for 92 patients. 92% of them were for generic drugs. CMS names the drug for 175 of them, across 7 drugs with 11 or more claims each, at $7,602 in total drug cost. In 2023, CMS named 200 claims across 8 drugs.

Dr. Codipilly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Codipilly as offering telehealth. CMS counts 433 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Codipilly, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 48 papers to Dr. Codipilly, published from 2017 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Esophageal Neoplasms, Barrett Esophagus and Adenocarcinoma. Dr. Codipilly has published most often in Gastrointest Endosc. Dr. Codipilly's most frequent co-authors are Prasad Ganapathy Iyer, MD, Cadman Lyle Leggett, MD and David A. Katzka, MD.

CMS Open Payments shows 5 general payments to Dr. Codipilly from 4 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Olympus America Inc. paid the most, $112.

Dr. Codipilly graduated from Renaissance School of Medicine at Stony Brook University in 2015. Dr. Codipilly is a member of AGA, AMA and ASGE.

Dr. Codipilly is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Medica. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.